2025Q4
| Insider | Role (last 12 mo) | Shares held | Filed at |
|---|---|---|---|
| Bartushak Jaime | — | 1,428,620 | Nov 12, 2024 |
| Czuczman Myron | — | 1,100,000 | Oct 12, 2023 |
| Mazur Leonard L | Chair | 538,814 | Sep 23, 2025 |
| Webb Carol | Director | 400,169 | Nov 12, 2024 |
| Holuka Eugene Myron | Director | 390,701 | Nov 12, 2024 |
| Exec date | Filing date | Insider | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 8, 2025 | Sep 23, 2025 | Mazur Leonard L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 8, 2025 | Aug 12, 2025 | HOLUBIAK MYRON Z | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 7, 2024 | Nov 12, 2024 | Webb Carol | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 7, 2024 | Nov 12, 2024 | Smith Robert Joseph | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 7, 2024 | Nov 12, 2024 | Bartushak Jaime | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 7, 2024 | Nov 12, 2024 | Mazur Leonard L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 7, 2024 | Nov 12, 2024 | Czuczman Myron | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 7, 2024 | Nov 12, 2024 | Dutia Suren G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 7, 2024 | Nov 12, 2024 | MCGRATH DENNIS M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 7, 2024 | Nov 12, 2024 | HOLUBIAK MYRON Z | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Nov 7, 2024 | Nov 12, 2024 | Holuka Eugene Myron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 14, 2024 | Sep 27, 2024 | HOLUBIAK MYRON Z | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 14, 2024 | Sep 27, 2024 | Mazur Leonard L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 13, 2024 | Aug 30, 2024 | Holuka Eugene Myron | Director | Sell | 27.5 | -48 | -1.99% | ✗ | $36 |
| Mar 4, 2024 | Aug 30, 2024 | Webb Carol | Director | Sell | 27.5 | -236 | -1.96% | ✗ | $180.8 |
| Apr 3, 2024 | Apr 5, 2024 | Mazur Leonard L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Apr 3, 2024 | Apr 5, 2024 | HOLUBIAK MYRON Z | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 14, 2024 | Mar 18, 2024 | Smith Robert Joseph | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Mar 18, 2024 | Smith Robert Joseph | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 10, 2023 | Oct 12, 2023 | Webb Carol | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 10, 2023 | Oct 12, 2023 | Czuczman Myron | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 10, 2023 | Oct 12, 2023 | HOLUBIAK MYRON Z | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 10, 2023 | Oct 12, 2023 | Holuka Eugene Myron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 10, 2023 | Oct 12, 2023 | MCGRATH DENNIS M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 10, 2023 | Oct 12, 2023 | Dutia Suren G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 10, 2023 | Oct 12, 2023 | Bartushak Jaime | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 10, 2023 | Oct 12, 2023 | Mazur Leonard L | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 7, 2023 | Feb 9, 2023 | MCGRATH DENNIS M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 9, 2023 | MCGRATH DENNIS M | Director | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Nov 15, 2022 | Mazur Leonard L | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Oct 4, 2022 | Oct 6, 2022 | Kane William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2022 | Oct 6, 2022 | Dutia Suren G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2022 | Oct 6, 2022 | HOLUBIAK MYRON Z | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2022 | Oct 6, 2022 | Mazur Leonard L | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2022 | Oct 6, 2022 | Bartushak Jaime | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2022 | Oct 6, 2022 | SAFIR HOWARD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2022 | Oct 6, 2022 | Holuka Eugene Myron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2022 | Oct 6, 2022 | Webb Carol | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 4, 2022 | Oct 6, 2022 | Czuczman Myron | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2021 | Oct 13, 2021 | HOLUBIAK MYRON Z | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2021 | Oct 13, 2021 | Mazur Leonard L | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2021 | Oct 13, 2021 | Webb Carol | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2021 | Oct 13, 2021 | Bartushak Jaime | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2021 | Oct 13, 2021 | SAFIR HOWARD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2021 | Oct 13, 2021 | Holuka Eugene Myron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2021 | Oct 13, 2021 | Dutia Suren G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2021 | Oct 13, 2021 | Czuczman Myron | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 11, 2021 | Oct 13, 2021 | Kane William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2021 | Jul 26, 2021 | Kane William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2021 | Jul 26, 2021 | Dutia Suren G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2021 | Jul 26, 2021 | HOLUBIAK MYRON Z | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2021 | Jul 26, 2021 | Mazur Leonard L | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2021 | Jul 26, 2021 | Bartushak Jaime | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2021 | Jul 26, 2021 | SAFIR HOWARD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2021 | Jul 26, 2021 | Holuka Eugene Myron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 22, 2021 | Jul 26, 2021 | Webb Carol | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2021 | Feb 18, 2021 | Kane William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2021 | Feb 18, 2021 | Dutia Suren G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2021 | Feb 18, 2021 | SAFIR HOWARD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2021 | Feb 18, 2021 | Holuka Eugene Myron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Feb 16, 2021 | Feb 18, 2021 | Webb Carol | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2020 | Oct 9, 2020 | Kane William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2020 | Oct 9, 2020 | Dutia Suren G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2020 | Oct 9, 2020 | HOLUBIAK MYRON Z | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2020 | Oct 9, 2020 | Mazur Leonard L | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2020 | Oct 9, 2020 | Bartushak Jaime | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2020 | Oct 9, 2020 | Holuka Eugene Myron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2020 | Oct 9, 2020 | SAFIR HOWARD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 6, 2020 | Oct 9, 2020 | Webb Carol | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 14, 2020 | Jul 15, 2020 | Czuczman Myron | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 15, 2020 | Czuczman Myron | Chief Medical Officer | Neutral | 52.5 | - | 0.00% | ✗ | - | |
| Jul 7, 2020 | Jul 9, 2020 | Webb Carol | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 7, 2020 | Jul 9, 2020 | Holuka Eugene Myron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 7, 2020 | Jul 9, 2020 | Kane William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 7, 2020 | Jul 9, 2020 | Dutia Suren G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Jul 7, 2020 | Jul 9, 2020 | SAFIR HOWARD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2019 | Oct 10, 2019 | Webb Carol | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2019 | Oct 10, 2019 | SAFIR HOWARD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2019 | Oct 10, 2019 | Mazur Leonard L | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2019 | Oct 10, 2019 | Kane William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2019 | Oct 10, 2019 | Holuka Eugene Myron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2019 | Oct 10, 2019 | HOLUBIAK MYRON Z | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2019 | Oct 10, 2019 | Dutia Suren G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Oct 8, 2019 | Oct 10, 2019 | Bartushak Jaime | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 27, 2019 | Sep 27, 2019 | Mazur Leonard L | Chair | Buy | 100.0 | +2,234,700 | 27.86% | ✗ | $2M |
| Sep 27, 2019 | Sep 27, 2019 | HOLUBIAK MYRON Z | CEO | Buy | 97.5 | +558,597 | 38.96% | ✗ | $500K |
| Apr 3, 2019 | Apr 5, 2019 | Mazur Leonard L | Chair | Buy | 100.0 | +1,165,048 | 16.99% | ✗ | $1.8M |
| Apr 3, 2019 | Apr 5, 2019 | HOLUBIAK MYRON Z | CEO | Buy | 90.0 | +129,450 | 9.93% | ✗ | $200K |
| Sep 4, 2018 | Sep 6, 2018 | Webb Carol | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2018 | Sep 6, 2018 | SAFIR HOWARD | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2018 | Sep 6, 2018 | Mazur Leonard L | Chair | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2018 | Sep 6, 2018 | Kane William | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2018 | Sep 6, 2018 | Holuka Eugene Myron | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2018 | Sep 6, 2018 | HOLUBIAK MYRON Z | CEO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2018 | Sep 6, 2018 | Dutia Suren G | Director | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Sep 4, 2018 | Sep 6, 2018 | Bartushak Jaime | CFO | Neutral | 52.5 | - | 0.00% | ✗ | - |
| Aug 13, 2018 | Aug 15, 2018 | Mazur Leonard L | Chair | Buy | 100.0 | +3,137,255 | 84.37% | ✗ | $4M |
| Aug 13, 2018 | Aug 15, 2018 | HOLUBIAK MYRON Z | CEO | Buy | 100.0 | +784,314 | 150.86% | ✗ | $1M |
| Mar 29, 2018 | Apr 2, 2018 | Mazur Leonard L | Chair | Buy | 90.0 | +167,504 | 4.72% | ✗ | $500K |
| Mar 28, 2018 | Mar 29, 2018 | HOLUBIAK MYRON Z | CEO | Buy | 67.5 | +2,915 | 0.56% | ✗ | $9K |